Maren Kühr's articles Biotechnology Revolutionising Oral Drug Delivery – European Biotechnology Magazine The challenge of oral drug delivery is ensuring that therapeutics survive the harsh GI conditions while achieving efficient intestinal uptake. NovoArc’s platform addresses this by engineering protective lipid-based carriers that stabilize APIs and enhance absorption. This technology enables oral delivery for medications like antibiotics, insulin, and mRNA vaccines. Nature-Inspired TechnologyNovoArc takes inspiration from nature. Microorganisms […] Written by Maren Kühr April 5, 2025April 5, 2025 Saving Bookmark this article Bookmarked Biotechnology CEO and Chairman of the Executive Board Jonathan Dickinson brings extensive biotech and pharma experience to Marseille-based Innate Pharma. He comes from Incyte, where he served as Executive Vice President and General Manager Europe since 2016. Prior to that, he gained significant leadership experience through several senior positions at oncology focused ARIAD Pharmaceuticals and Bristol-Myers Squibb. This followed a distinguished 13-year tenure […] Written by Maren Kühr November 3, 2024November 3, 2024 Saving Bookmark this article Bookmarked
Biotechnology Revolutionising Oral Drug Delivery – European Biotechnology Magazine The challenge of oral drug delivery is ensuring that therapeutics survive the harsh GI conditions while achieving efficient intestinal uptake. NovoArc’s platform addresses this by engineering protective lipid-based carriers that stabilize APIs and enhance absorption. This technology enables oral delivery for medications like antibiotics, insulin, and mRNA vaccines. Nature-Inspired TechnologyNovoArc takes inspiration from nature. Microorganisms […] Written by Maren Kühr April 5, 2025April 5, 2025 Saving Bookmark this article Bookmarked
Biotechnology CEO and Chairman of the Executive Board Jonathan Dickinson brings extensive biotech and pharma experience to Marseille-based Innate Pharma. He comes from Incyte, where he served as Executive Vice President and General Manager Europe since 2016. Prior to that, he gained significant leadership experience through several senior positions at oncology focused ARIAD Pharmaceuticals and Bristol-Myers Squibb. This followed a distinguished 13-year tenure […] Written by Maren Kühr November 3, 2024November 3, 2024 Saving Bookmark this article Bookmarked
